The Lived Experience of Talquetamab Therapy in a Patient With Multiple Myeloma
Karen Kehl shares her decade-long journey with multiple myeloma, discussing treatment options and the impact of bispecific antibodies like talquetamab with Binod Dhakal, MD.
Multidisciplinary Team Discusses Practical Treatment Options in NSCLC
Experts at City of Hope explore innovative immunotherapy strategies for non-small cell lung cancer, highlighting efficacy and toxicity management in treatment.
Boston’s Best Did Not “Leave the Cannoli” in Battle of Lymphoma Top Trials
Two teams of lymphoma experts engage in a face-off competition, showcasing real-world updates, patient cases, and use of ASCT or CAR T-cell therapy.
Employing Comprehensive Genomic Testing in the NSCLC Paradigm
An expert discusses the vital role of comprehensive genomic profiling in personalizing treatment for non-small cell lung cancer, enhancing patient outcomes.
CEPHEUS Highlights Efficacious, Safe Regimen for Transplant-Ineligible/Deferred Multiple Myeloma
Recent advancements in multiple myeloma treatment highlight the efficacy of daratumumab combined with VRd, showcasing improved outcomes and tolerability.
Evaluating the Top EGFR+ NSCLC Treatment Combinations
Experts discuss evolving therapies for EGFR-mutated metastatic NSCLC, comparing combination regimens and their impact on patient outcomes.
